Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
28th Jul 2017 3:51 pm RNS Director/PDMR Shareholding
26th Jul 2017 1:22 pm RNS Director/PDMR Shareholding
26th Jul 2017 12:41 pm RNS Director/PDMR Shareholding - Replacement
26th Jul 2017 11:00 am RNS Half-year Report
25th Jul 2017 1:30 pm RNS ViiV announces results from NEAT 022 study
25th Jul 2017 1:30 pm RNS ViiV announces positive results from DAWNING
24th Jul 2017 9:02 am RNS LATTE-2 phII results presented at IAS in Paris
21st Jul 2017 3:34 pm RNS Director/PDMR Shareholding
21st Jul 2017 3:30 pm RNS Director/PDMR Shareholding
21st Jul 2017 1:59 pm RNS GSK submits EU filing for Relvar Ellipta extension
21st Jul 2017 11:00 am RNS Directorate Change
17th Jul 2017 6:08 pm RNS Director/PDMR Shareholding
17th Jul 2017 5:44 pm RNS Director/PDMR Shareholding
14th Jul 2017 4:58 pm RNS Director/PDMR Shareholding
14th Jul 2017 4:46 pm RNS Director/PDMR Shareholding
14th Jul 2017 4:02 pm RNS Director/PDMR Shareholding
14th Jul 2017 11:57 am RNS Director/PDMR Shareholding
12th Jul 2017 4:12 pm RNS Director/PDMR Shareholding
3rd Jul 2017 10:05 am RNS Total Voting Rights
28th Jun 2017 4:13 pm RNS GSK announces US filing for mepo in EGPA
27th Jun 2017 10:06 am RNS GSK starts phIII study on mepo for nasal polyps
21st Jun 2017 2:35 pm RNS Director/PDMR Shareholding
21st Jun 2017 2:05 pm RNS GSK presents Shingrix PhIII study results at ACIP
19th Jun 2017 4:29 pm RNS GSK confirms start date for Luke Miels
12th Jun 2017 4:43 pm RNS Director/PDMR Shareholding
5th Jun 2017 5:23 pm RNS Director/PDMR Shareholding
2nd Jun 2017 7:00 am RNS ViiV submits first 2-drug HIV regimen application
1st Jun 2017 10:58 am RNS Total Voting Rights
31st May 2017 4:25 pm RNS Director/PDMR Shareholding
22nd May 2017 4:45 pm RNS Director/PDMR Shareholding
22nd May 2017 4:40 pm RNS Director/PDMR Shareholding
22nd May 2017 2:23 pm RNS Ph3 MUSCA study presented at ATS
18th May 2017 7:00 am RNS NEJM publication of PH3 study into Mepo in EGPA
12th May 2017 4:26 pm RNS Block listing Interim Review
11th May 2017 5:29 pm RNS Director/PDMR Shareholding
10th May 2017 4:26 pm RNS Headline Phase III results: Mepo in COPD
5th May 2017 12:39 pm RNS Rellvar Ellipta 2nd Salford Lung Study Results
4th May 2017 6:10 pm RNS Result of AGM
2nd May 2017 1:02 pm RNS Director/PDMR Shareholding
2nd May 2017 10:02 am RNS Total Voting Rights
FTSE 100 Latest
Value8,941.12
Change-34.54